NEW YORK (GenomeWeb) — ImiDomics announced today that it has partnered with Celgene to advance Celgene's development of new treatments for immune-mediated inflammatory diseases.
Already have a GenomeWeb or 360Dx account?Login Now.
An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.
Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.
The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.
In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.